Prostate Cancer

Cat 1 · 30 days

appointment within 30 calendar days. - Patients with new or suspected diagnosis of prostate cancer should be referred initially to the Urology service for a conclusive diagnosis and initial management and are usually discussed in a multidisciplinary team meeting and referred to a Medical oncologist for escalation of care if considered appropriate - Metastatic prostate cancer. For optimum care, patient should be seen within 4 weeks - Symptomatic patients with radiological evidence of locally advanced or metastatic disease and PSA > 50 ng/mL. (Note: Asymptomatic patients should be referred to a specialist urologist within 4 weeks of a persistently abnormal PSA result or a single PSA reading ≥ 10 ng/mL)

Cat 2 · 90 days

appointment within 90 calendar days. - New diagnosis of castrate resistant non-metastatic prostate cancer currently receiving androgen deprivation therapy and demonstrating evidence of a prostate-specific antigen level that was observed to have at least doubled in value in a time period of within 10 months anytime prior to first commencing treatment with this drug - New diagnosis of hormone sensitive metastatic prostate cancer for consideration of escalation of therapy from androgen deprivation therapy alone (within 6 months of commencement of androgen deprivation therapy) to include a novel anti-androgens +/- chemotherapy (Note: patients should have a histological diagnosis of prostate cancer) - Transfer of care from another health service

Cat 3 · 365 days

appointment within 365 calendar days. - No category 3 criteria